CFB OGPAE02-2 Physiology Of Lactation, Breast Feeding And Infant Feeding (part II)
Lactation physiology involves the hormonal regulation of milk production and ejection, alongside the principles of breastfeeding techniques and appropriate infant feeding practices to ensure optimal neonatal nutrition and growth.
This lecture (Part II) is the paediatrics perspective on infant feeding, complementing the OG Part I lecture (which focuses on breast anatomy, hormonal physiology of lactation, and the let-down reflex). Part II covers the practical, clinical, and nutritional science of feeding the newborn and infant — from the first hours of life through to complementary feeding (weaning) at around 6 months and beyond.
Big Idea: Human milk is a dynamic biological system whose composition changes with lactation and which provides nutrition plus bioactive protection. When breastfeeding or expressed human milk is unavailable, insufficient, or contraindicated, the paediatrician chooses a nutritionally complete substitute or a condition-specific feed. Complementary foods are introduced at about 6 months, guided by developmental readiness, while milk feeding continues.
Learning objectives (derived from slides):
- Understand basic concepts of early infant nutrition (growth parameters, fluid requirements, developmental maturation of GI tract, energy balance).
- Articulate why breast is best — nutritional, immunological, health, neurodevelopmental, and preterm-specific benefits.
- Describe breastfeeding awareness and practices in hospital, including the Baby Friendly Hospital Initiative and WHO/UNICEF Ten Steps.
- Identify potential issues in breastfeeding (foremilk-hindmilk imbalance, insufficient milk, jaundice, excessive weight loss, neonatal hypoglycaemia).
- Know the indications and types of infant formulas and special formulas.
- Understand complementary feeding — what, when, how, do's and don'ts.
1. Basic Concepts of Early Infant Nutrition
Term vs preterm; growth parameters (weight, length, head circumference); AGA vs SGA vs LGA; symmetrical vs asymmetrical SGA; LBW ( < 2.5 kg), VLBW ( < 1.5 kg), and ELBW ( < 1 kg). [1]
| Term | Definition | Why It Matters |
|---|---|---|
| AGA | Appropriate for gestational age (weight between 10th–90th centile) | Baseline reference for normal growth |
| SGA | Small for gestational age (weight < 10th centile) | At risk for hypoglycaemia, hypothermia, polycythaemia |
| LGA | Large for gestational age (weight > 90th centile) | Often associated with maternal diabetes; risk of birth trauma, hypoglycaemia |
| Symmetrical SGA | Head, length, and weight all proportionally small | Suggests early insult (e.g. chromosomal anomaly, congenital infection — TORCH) — insult occurred in 1st trimester when both cell number and size are affected |
| Asymmetrical SGA | Head circumference relatively preserved, body/weight disproportionately small | Suggests late-onset placental insufficiency — brain-sparing effect; typically 3rd trimester |
| LBW | Birth weight < 2.5 kg | Increased risk of neonatal morbidity; includes both preterm and growth-restricted infants |
| VLBW | Birth weight < 1.5 kg | High risk of complications related to prematurity and limited nutrient stores |
| ELBW | Birth weight < 1 kg | Extremely high risk of all neonatal complications |
Day 0–4: fluid loss up to 7% of birth weight. Day 5–7: starts gaining weight. Fluid requirements increase and reach 150–180 ml/kg/day by day 7. [1]
Why this matters: Newborns are born with excess extracellular fluid, so some early diuresis and weight loss are expected. The slide uses up to 7% as its term-infant teaching figure. Interpret the trajectory with age in hours, gestation, delivery mode, feeding effectiveness, urine/stool output, and the local newborn-weight nomogram. A loss around 10% is an assessment trigger, not a stand-alone diagnosis and not a reason to supplement automatically; rapid or excessive loss requires prompt feeding and clinical assessment. [10]
- Day 0: fluid needs are very low (~60 ml/kg/day for term infants)
- Fluid needs escalate daily as renal function matures and insensible losses increase
- By day 7, many neonatal fluid prescriptions reach ~150–180 ml/kg/day, but actual prescriptions are individualized for gestation, renal function, insensible losses, illness, and enteral tolerance
11 weeks: fetal swallowing starts. 24 weeks: GIT anatomically completed. 28 weeks: GIT peristalsis. 33–36 weeks: coordinated suckling and swallowing. Functional development continues into infancy — digestion and absorption. [1]
| Gestational Age | GI Milestone | Clinical Implication |
|---|---|---|
| 11 wk | Fetal swallowing starts | Swallows amniotic fluid (contributes to fluid homeostasis) |
| 24 wk | GIT anatomically completed | Anatomic but NOT functional maturity |
| 28 wk | GIT peristalsis begins | Can begin trophic feeds in very preterm infants |
| 33–36 wk | Coordinated suck-swallow | Before this, infants cannot safely feed orally — need NG/OG tube feeds |
| Infancy onwards | Ongoing maturation of digestion and absorption | Pancreatic amylase increases after 6 months; lipase approaches adult levels by 6 months [3] |
Why coordinated suck-swallow matters: Premature babies < 33–34 weeks cannot safely coordinate sucking, swallowing, and breathing simultaneously. This is why they require gavage (tube) feeding and why oral feeds are only introduced once this coordination develops.
1. Achieve appropriate growth and development. 2. Compensate additional demand during disease state. 3. Prevent complications of nutritional deficiency or excess. [1]
Positive energy balance (gain) = intake > basal + expenditure. Expenditure includes activity, thermoregulation, digestion/metabolism, fecal loss, urine, heat loss by radiation and evaporation. Requirements: protein, fat, carbohydrates, minerals, vitamins, water. [1]
Normal infant growth is multifactorial: gestation, age, sex, ethnicity, feeding regimen, medical conditions, and even generational factors.
Protein: Preterms need more for growth. Whey protein (~60% in breast milk, 40% casein) — soluble upon acidification, easier digestion; contains essential amino acids, immunoproteins, and enzymes. [1]
Fat: 40–52% daily caloric intake; at least 3% total calories from linoleic acid. LC-PUFA important for growth, brain and retinal development. [1]
Carbohydrates: Glycogen stores from 2nd trimester, exhausted in 12–24 hours. Normal glucose utilization rate (GUR): 4–6 mg/kg/min (term), 4–8 mg/kg/min (preterm). [1]
| Macronutrient | Key Points | Clinical Relevance |
|---|---|---|
| Protein | Whey:Casein ratio in BM = 60:40 (mature milk) to 80:20 (some sources); colostrum 90:10. Whey is easier to digest. | Preterms need higher protein for catch-up growth. Whey contains lactoferrin, lysozyme, sIgA |
| Fat | 40–52% of calories. LC-PUFA (DHA, ARA) essential for brain/retinal development | Breast milk contains lipase for fat digestion; formula lacks this |
| Carbohydrate | Lactose is primary CHO in breast milk. Glycogen exhausted in 12–24h | Preterm/SGA babies at risk of hypoglycaemia because glycogen stores are limited |
Preterms: insensible water loss, catch-up growth, inadequate nutrient storage (glycogen, fat, calcium, iron, Vit D). Disease states: higher energy requirement. Fluid restriction in RDS/chronic lung/heart failure vs liberal in sepsis/NEC/IUGR. [1]
Respiratory quotient (RQ) = CO₂ produced / O₂ consumed: carbohydrate (1.0), protein (~0.8), fat (~0.7). The slide proposes less carbohydrate and proportionally more fat in chronic lung disease. [1]
Clinical interpretation: Avoid overfeeding, which raises CO₂ production. A lower-carbohydrate, higher-fat energy distribution can reduce CO₂ generation in selected ventilatory-limited infants, but “restrict carbohydrate” is not a universal prescription: adequate glucose delivery, protein, essential fatty acids, growth, and feed tolerance still matter, and neonatal dietetic input is required.
Inborn errors of metabolism: dietary restrictions to avoid accumulation of harmful metabolites. [1]
2. "Breast is Best" — Why Breastfeeding is Superior
High Yield — Core Exam Theme
"Breast is best" — the slide repeatedly returns to five pillars: (1) Composition/volume adjusted to infant's growing needs, (2) Protection against infections/inflammation/atopy, (3) General health/cardiovascular/metabolic benefits, (4) Neurodevelopmental benefits, (5) Special benefits in preterm babies. [1]
Composition and volume adjusted to infants' growing needs. [1]
The composition of breast milk changes dynamically:
| Lactation period | Milk type | Energy (kcal/dL) | Lipid (g/dL) | Protein (g/dL) | Lactose (g/dL) |
|---|---|---|---|---|---|
| 3–5 days | Term | 48 | 1.85 | 1.87 | 5.14 |
| Preterm | 58 | 3.00 | 2.10 | 5.04 | |
| 15–18 days | Term | 62 | 3.06 | 1.52 | 6.00 |
| Preterm | 71 | 4.33 | 1.71 | 5.63 | |
| 26–29 days | Term | 62 | 3.05 | 1.29 | 6.51 |
| Preterm | 70 | 4.09 | 1.41 | 5.97 |
Key observations:
- Preterm milk is higher in energy, lipid, and protein than term milk — nature compensates for the premature baby's higher metabolic demands [1]
- Protein content decreases over the first month as growth velocity declines
- Lactose increases as the infant matures
Growth velocity and protein/fat accretion are highest at birth and decline with age. [1]
The stacked-bar figure separates daily weight gain into water, fat, protein, and other solids. Its central message is the falling growth velocity, not a fixed prescription:
| Age | Approximate total gain shown | Visual interpretation |
|---|---|---|
| Birth–2 months | ~31 g/day | Fastest gain; water is the largest component, with substantial fat and protein accretion |
| 2–4 months | ~24 g/day | All components fall, especially water accretion |
| 4–6 months | ~16 g/day | Growth velocity continues to slow |
| 6–9 months | ~13 g/day | More gradual tissue accretion |
| 9–12 months | ~10–11 g/day | Lowest rate shown |
These are approximate values read from the lecture graph, not centile cut-offs. Assess growth longitudinally with weight, length, and head circumference rather than comparing one infant with a single average.
Mature human milk vs Enfamil (cow) vs Similac (cow) vs Isomil (soy) — per 100 Cal (i.e. 150 ml of 20 Cal/oz) [1]
How to read this historical product table
The following values are the specific products and formulations pictured in the lecture, not universal modern formula composition. Brands reformulate and regulated nutrient contents sit within permitted ranges. Use the table to compare the lecturer's pattern (human milk has lower protein/renal solute load and more bioactive components), not to memorize a current product label. Hong Kong's 2014 amendment requires infant formula energy plus 33 specified nutrients to meet composition limits; the composition provisions took effect in December 2015. [15]
| Component | Mature HM | Cow-based (Enfamil) | Cow-based (Similac) | Soy-based (Isomil) |
|---|---|---|---|---|
| Protein (g) | 1.8 | 2.1 | 2.07 | 2.45 |
| Whey:Casein | 80:20 | 60:40 | 48:52 | -- |
| Fat (g) | 4.3–4.9 | 5.3 | 5.4 | 5.46 |
| CHO (g) | 11 | 10.9 | 10.8 | 10.3 |
| Iron (mg) | 0.05–0.075 | 1.8 | 1.8 | 1.8 |
| Vit D (IU) | 3 | 60 | 60 | 60 |
| Renal solute load (mOsm) | 14 | 19.2 | 18.7 | 22.8 |
| Osmolality (mOsm/kg H₂O) | 290–305 | 300 | 300 | 200 |
Slide-derived comparison points:
- Breast milk has the LOWEST renal solute load (14 mOsm) — gentler on immature neonatal kidneys [1]
- The pictured human-milk column contains little vitamin D and iron. Supplementation depends on local guidance, gestation, birth stores, diet, and risk. For example, AAP guidance gives breastfed/partly breastfed infants vitamin D 400 IU/day and provides separate iron recommendations; preterm infants require specific multivitamin and iron planning. [11]
- Breast milk has a higher whey:casein ratio (80:20) than cow-based formulas — whey is more digestible [1]
- Formula has much higher iron and Vit D because of these known deficiencies in breast milk
Exam Trap – Iron and Vitamin D in Breast Milk
Human milk alone usually does not provide enough vitamin D, and iron planning becomes important as fetal stores decline. Do not infer a universal dose from the old comparison table: apply the local infant-supplementation schedule and distinguish healthy term infants from preterm/LBW infants. [11]
2.3 Immunological Protection
Breastmilk provides immunological protections: matches developmental sequence of postnatal immune system; helps GI tract adaptation from fetal to postnatal life; contains 3 overlapping groups of bioactive agents: direct-acting antimicrobial, anti-inflammatory, and immunomodulating agents; harbours complex in-vivo interactions; offers stable milk compositions even in malnourished mothers. [1]
This is a crucial concept: the infant's own immune system is immature at birth, and breast milk acts as an external immune supplement during the critical window before the baby's immune system matures.
| Agent | Function |
|---|---|
| Lactoferrin | Bacteriostasis via iron chelation; direct bacterial killing; trophic for intestinal growth; inhibits E. coli |
| Lysozyme | Lyses bacterial cell walls |
| Secretory IgA (sIgA) | Binds bacterial adherence sites and toxins — coats intestinal mucosa |
| Antimicrobial mucins | Inhibits binding of S-fimbriated E. coli to epithelial cells |
| Lactadherin | Binds rotavirus, prevents contact with epithelium |
| Oligosaccharides | Inhibit binding of enteric/respiratory pathogens and their toxins to epithelial cells; act as prebiotics |
Why sIgA is so important: The infant does not produce its own secretory IgA until ~4–12 months. During this window, breast milk sIgA provides passive mucosal immunity — it coats the gut lining, preventing pathogen attachment. This is why breastfeeding is so protective against gastroenteritis. [1]
| Agent | Function |
|---|---|
| EGF, TGF (growth factors) | Luminal surveillance, intestinal repair, promote epithelial cell growth |
| PAF-acetylhydrolase | Blocks action of PAF (platelet activating factor) — a mediator of NEC |
| Glutathione peroxidase | Prevents lipid oxidation |
| Uric acid, Vit A, E, C | Antioxidants |
| Cortisol | Maturating factors |
| PGE₂ | Cytoprotective agents |
| IL-10 | Modulator of leucocytes (anti-inflammatory cytokine) |
| Agent | Function |
|---|---|
| β-Casomorphin | Activates macrophages |
| Prolactin | Enhances T-cell development |
| α-Tocopherol | Augments cell-mediated immunity |
| Cytokines (IFN, IL-6, TNF, G-CSF, M-CSF) | Activate macrophages, enhance IgA production, enhance Ig receptors |
| Nucleotides | Enhance NK cell, macrophage, T helper activities and antibody formation |
sIgA: ~4–12 months. Full antibody repertoire: ~2 years. Memory T cells: ~2 years. Lysozyme: ~1–2 years. [1]
These ages are approximate teaching ranges from the slide. They illustrate that immune maturation is gradual and human milk can provide mucosal support during that transition. They do not by themselves prove a minimum breastfeeding duration; recommendations to continue to 2 years or beyond integrate nutrition, infection protection, maternal benefit, feasibility, and family preference. [11][12]
Gambia vs UK: Energy, protein, fat, lactose essentially IDENTICAL. Immunoproteins actually HIGHER (145% of UK levels) in Gambian mothers' milk. Only vitamins are reduced (49–200% of UK). [1]
Interpret carefully: This is a small historical comparison (Gambia vs UK), not proof that every component is preserved in every nutritional deficiency. Macronutrient concentration can be relatively resilient, while maternal diet/status can affect some micronutrients and fatty acids. Support breastfeeding and assess and treat maternal malnutrition; do not use this table to dismiss maternal nutritional needs.
The slide lists lower rates of gastroenteritis, respiratory illness, UTI, NEC, childhood leukaemia, cardiovascular risk factors, ear infection, SIDS, diabetes, and atopic disease among breastfed infants. [1]
Evidence hierarchy — association is not equal across outcomes
The most consistent benefits are fewer gastrointestinal/respiratory infections and, in preterm infants, a lower risk of NEC with human milk. Many longer-term outcomes come from observational studies and are vulnerable to socioeconomic, parental, and health-selection confounding. State these as associations unless a cited trial or systematic review supports a causal claim; do not promise that breastfeeding “prevents” every condition on the slide. [11]
The slide presents an observational dose–response between breastfeeding duration and later IQ (Mortensen) and the cluster-randomized PROBIT breastfeeding-promotion trial, which found less gastrointestinal infection/eczema in infancy and higher cognitive-test scores at 6.5 years. [1]
How to interpret the figure: Duration–IQ curves alone cannot remove residual confounding. PROBIT randomized a promotion intervention, not breastfeeding itself, and therefore provides stronger—but still indirect—causal evidence. The safe exam phrasing is that breastfeeding is associated with modest neurodevelopmental benefit, with some supportive promotion-trial evidence.
Preterm babies need: match intrauterine growth rate (15–20 g/kg/day), higher caloric requirement, prevention of NEC. [1]
The balance diagram contrasts the growth nutrients in preterm formula (higher energy/protein/minerals) with the gut, immune, and bonding advantages of human milk. [1]
The diagram is not an either/or choice. In modern practice the usual hierarchy is:
- Mother's own milk for preterm/LBW infants.
- Donor human milk when mother's own milk is unavailable, where safe milk banking is available.
- Consider multicomponent fortification for very preterm (< 32 weeks) or VLBW (< 1.5 kg) infants to meet protein/mineral needs.
- Consider nutrient-enriched preterm formula when human milk options are unavailable or insufficient under a neonatal plan. [13]
Human milk in preterms provides: ↓ infection, 6.5-fold ↑ NEC in formula-fed (Lucas, Lancet 1990), protective dose > 50 ml/kg/day against late-onset sepsis, NEC prevention (Cochrane review). [1]
Benefits of human milk as trophic feeding: maturation/adaptation of premature GI tract, full enteral feeding achieved earlier, mothers who initiate lactation early more likely to sustain, psychological wellbeing, better neurodevelopmental outcomes (8-pt advantage at 8 years; higher visual acuity scores at 2–6 months; 5-point Bayley MDI increase per 100 ml/kg/day). [1]
NEC and human milk — lecture figure vs current takeaway
The 6.5-fold number is the lecture's historical Lucas 1990 estimate and may be examinable as a slide fact; it is not a timeless universal effect size. The durable clinical takeaway is that human milk—mother's own milk first, donor milk when appropriate—is associated with less NEC than formula in preterm/LBW infants. [13]
For breastmilk-fed preterms < 1.5 kg: breastmilk fortification with human milk or formula fortifiers is recommended to optimize protein content. [1]
3. Breastfeeding Practices in Hospital
Problems: aggressive marketing + poor hospital policies. Solutions: Baby Friendly (Hospital) Initiatives. WHO International Code and national legislation. WHO/UNICEF Ten Steps to Successful Breastfeeding. [1]
The BFHI was launched by WHO/UNICEF in 1991 to ensure that all maternity facilities support breastfeeding. Key points:
- Hospitals should NOT distribute free formula samples (aggressive marketing from formula companies undermines breastfeeding)
- The WHO International Code of Marketing of Breast-milk Substitutes restricts formula advertising
The slide shows the older programme poster. The 2018 revised Ten Steps retain the same intent but divide it into institutional procedures (Code compliance, written policy/data monitoring, competent staff) and clinical practices (antenatal discussion, immediate skin-to-skin contact, skilled feeding support, no non-indicated supplements, rooming-in, cue-based feeding, counselling about bottles/teats/pacifiers, and coordinated follow-up). [14]
Historical Hong Kong discharge-rate graph
The BFHIHKA line graph rises from about 19% in 1992 to about 79% in 2010, with a plateau around the low-to-mid 60s in 2002–2006 followed by a steeper rise. It illustrates population-level change alongside hospital/policy efforts. Label it carefully: this is historical breastfeeding at maternity discharge, not current prevalence, not necessarily exclusive breastfeeding, and not duration after discharge. The two arrows in the slide are not captioned, so no specific policy event should be inferred from them.
Colostrum: contains all necessary nutrients, protects against infections, has a laxative effect, comes in small volumes. [1]
Why the laxative effect matters: Colostrum helps the newborn pass meconium, which contains bilirubin. Early meconium passage reduces enterohepatic circulation of bilirubin, helping to prevent neonatal jaundice.
Formula can provide regulated nutrition when needed, but it does not reproduce the full, changing cellular, immunological, hormonal, oligosaccharide, and enzyme milieu of human milk. Avoid the slide's absolute implication that formula contains “none” of any bioactive ingredient; formulations vary and may include selected added components, though they are not equivalent to the living human-milk system.
Initiate BF within 1st hour, then exclusive BF for first 6 months. On-demand feeding. No bottles, teats, or pacifiers. Infants not exclusively BF need suitable breastmilk substitutes. At around 6 months: start safe and adequate complementary foods while continuing BF for up to 2 years and beyond. [1]
Encourage skin contact and early feeding after delivery. Kangaroo care. Value colostrum. Avoid unnecessary supplements and discourage teats/dummies. Avoid mother-baby separation. Encourage frequent feeding. Prescribe medications with care. Be supportive. Identify and care for "at-risk" babies (neonatal hypoglycaemia). [1]
The kangaroo-care photographs deliberately show both a mother and a father and include a very preterm infant receiving respiratory support. The visual point is that skin-to-skin care is family-participatory care, not limited to mothers or healthy term newborns; monitoring, lines and respiratory equipment require neonatal-team coordination rather than automatically precluding it. WHO recommends kangaroo mother care routinely for preterm/LBW infants and initiation as soon as possible after birth. [13]
4. Potential Issues in Breastfeeding During Early Days
Excess lactose in stool → loose, frothy, green stools and symptoms of colic. Low fat intake → inadequate intake of fat-soluble vitamins. [1]
What the diagram actually shows: milk fat concentration usually rises gradually as a breast becomes less full; there is no anatomical switch that suddenly changes “foremilk” into “hindmilk.” The labels describe relative samples, not two separate kinds of milk.
Current interpretation — do not diagnose by stool colour
The slide's “foremilk–hindmilk imbalance” explanation is controversial and commonly overdiagnosed. Green/frothy stools alone do not prove lactose overload or fat-soluble-vitamin deficiency. Assess weight gain, latch and milk transfer, feed frequency, maternal oversupply/fast flow, blood or mucus in stool, infection, and cow's-milk-protein allergy when appropriate. Avoid rigidly timing each breast; support responsive feeding and allow effective feeding on the first side before offering the second.
Ineffective attachment and/or infrequent feeding → ↓↓↓ breast milk production → fail to sustain breastfeeding. [1]
Mechanism from first principles: Milk production depends substantially on effective and frequent milk removal. Prolactin supports synthesis and oxytocin drives ejection. If the baby does not attach or transfer milk well, or feeds too infrequently:
- Less nipple stimulation → less prolactin → less milk production
- Less milk removal and greater alveolar distension → local down-regulation of synthesis → further ↓ production
- This creates a vicious cycle leading to lactation failure
Effective vs ineffective attachment: ineffective attachment → nipple soreness and cracks. [1]
Key signs of effective attachment: baby's mouth wide open, chin touching breast, lower lip turned outward, more areola visible above than below the mouth, audible swallowing.
Jaundice → lethargy → infrequent/inefficient feeds → reduced milk intake → fewer calories/less energy → reduced gut motility → re-absorption of bilirubin → reduced breastmilk supply → MORE jaundice. [1]
The slide's circular graphic is important because it shows two reinforcing limbs:
Jaundice → lethargy → infrequent/ineffective feeding → ↓ intake
↘ ↓ milk removal → ↓ supply ↗
↓ intake → ↓ energy + ↓ gut motility → ↑ enterohepatic bilirubin reabsorption
→ more jaundiceManagement: Keep mother and baby together, frequent feeds, help from lactation consultant, express breastmilk and give (if necessary), AVOID WATER. [1]
Breastfeeding Jaundice vs Breastmilk Jaundice
Breastfeeding jaundice (early, 1st week): due to INADEQUATE breastfeeding → dehydration, ↓gut motility, ↑enterohepatic circulation. Manage by improving breastfeeding.
Breast milk jaundice (usually begins in the second or later week and can persist for weeks): the exact mechanism is not fully established. It is a diagnosis made after assessing the infant and excluding pathological causes; most infants continue breastfeeding. [4][5][16]
Both cause UNCONJUGATED hyperbilirubinaemia. The key discriminator is TIMING.
Causes: ineffective attachment, infrequent/restricted feeding, underlying illness. Management: exclude underlying illness, keep mother and baby together, skilled help with attachment, frequent feeds, express breastmilk, monitor I/O and weight. [1]
The slide labels weight, stools, urine, and feeding history as useful, and dry mouth/skin, sunken fontanelle, early serum sodium, and unsettled behaviour as “unreliable.” [1]
Safety correction — no single sign rules dehydration in or out
The slide should not be read as “ignore sodium.” Clinical signs can be subtle and no single sign is sufficiently sensitive. Use the complete picture: serial weight plotted by age, observed milk transfer, urine/stool pattern, jaundice, alertness, perfusion, and examination. If loss is excessive, intake is poor, or the baby is unwell, check indicated investigations—including electrolytes. Hypernatraemia is a clinically important complication, not a physiological reassurance. Weight loss > 10%, > 75th centile on a newborn-weight nomogram, or fewer than one void and stool per day of life should trigger careful breastfeeding assessment. [10]
Risk factors: Prematurity, SGA, compromised states (hypothermia, asphyxia, critically ill), maternal diabetes or beta-blocker therapy. Impaired counter-regulatory response; risk of neurological impairment if prolonged. [1]
Care: skin contact, early and regular feeds, warmth, close monitoring, colostrum. [1]
Why SGA babies are at risk: They have limited glycogen and fat stores, so when the transplacental glucose supply is cut at birth, they can't mount adequate gluconeogenesis or glycogenolysis.
Why infants of diabetic mothers (IDM) are at risk: Maternal hyperglycaemia → fetal hyperinsulinaemia (islet cell hyperplasia). After birth, the glucose supply stops but the high insulin levels persist → rebound hypoglycaemia.
Reading the paired graphs: both panels are individual SGA case traces, not treatment thresholds. In the breastfed infant, glucose falls transiently while ketones rise, demonstrating an alternative-fuel response. In the formula-fed infant shown, ketones remain low despite a low early glucose. The image illustrates possible metabolic adaptation; it does not prove that a low glucose is safe, that feeding type alone caused the difference, or that ketone production replaces local screening/treatment thresholds. Symptoms, risk category, age in hours, persistence, and the validated whole-blood/plasma method determine management.
Breast milk not available/inadequate; BF inappropriate due to specific medical conditions; baby needs special formulas (intolerance, allergy, IEM); mother taking contraindicated medications; mother is HIV-positive; mother unable to breastfeed; mother made informed decision not to breastfeed. [1]
HIV is not a universal blanket contraindication
The slide's unqualified “mother is HIV-positive” bullet is outdated. Infant-feeding advice depends on national policy, access to safe replacement feeding, maternal antiretroviral therapy, viral suppression, and shared decision-making. WHO supports breastfeeding with lifelong effective ART in settings whose national guidance endorses it; other health systems may recommend replacement feeding or individualized counselling. [12]
6. Infant Formulas — Indications and Types
1 Energy + 33 essential nutrients. Standards: WHO CODEX Alimentarius Commission Standards (Revised 2007); HK Food and Drugs Regulation 2014. [1]
In Hong Kong this is not merely historical: the 2014 amendment requires infant formula to meet specified energy and nutrient-composition ranges and to carry mandatory nutrition labelling; the main infant-formula requirements have applied since December 2015. [15]
| Feed | Main protein source | Typical fat source | Main carbohydrate pattern |
|---|---|---|---|
| Human milk | Human whey/casein plus many bioactive proteins | Human-milk triglycerides | Predominantly lactose plus human-milk oligosaccharides |
| Standard cow's-milk formula | Modified cow's-milk proteins | Usually a blend of vegetable and/or dairy fats | Usually lactose, sometimes other permitted carbohydrate sources |
| Soy formula | Soy-protein isolate | Vegetable oils | Non-lactose carbohydrate sources |
The slide's product examples are historical. The safe way to use the image is to identify the nutrient source and medical indication, then check the current product label; do not infer that all products in a category have identical ingredients.
| Type | Caloric Density | Indication |
|---|---|---|
| Standard | 20 kcal/oz (66 kcal/100ml) | Healthy term infants |
| Preterm | 24 kcal/oz or 30 kcal/oz | Preterm < 34 wk and/or BW < 2 kg |
| Enriched/Discharge | Often 22 kcal/oz (73 kcal/100 ml) | Selected former preterm infants; duration is individualized to growth and biochemical/nutritional status, not automatically 9–12 months corrected age |
| Cow's milk protein | Standard | Routine use |
| Soy-protein based | Standard | Specific indications (see CMPA section) |
| Hydrolysate (partial/extensive) | Variable | Extensively hydrolysed: first-line substitute for many CMPA cases; partially hydrolysed is not treatment for CMPA |
| MCT-enriched | Variable | Fat malabsorption, cholestasis, chylothorax, VLCAD |
| Lactose-free | Standard | Primary/secondary lactose intolerance |
| Amino acid based | Variable | Severe CMPA, anaphylaxis/high-risk presentations, or failure/intolerance of an extensively hydrolysed formula |
| Renal formula | Variable | CRF, hypercalcaemia |
Specialty formulas are medical feeds. Match the exact diagnosis and current composition with neonatal/metabolic/renal/dietetic advice; similar-looking tins are not interchangeable. [17][18]
Term: 110 kcal/kg/day (1st month), 95 kcal/kg/day (3–6m), 80 kcal/kg/day (6–12m). Preterm: 120 kcal/kg/day at 150 ml/kg/day. Preterm formulas: high protein, Ca, PO₄; additional Vit A, D, folate, zinc, iron; contains MCT, long-chain fats, glucose polymers, lactose. For BM-fed preterms < 1.5 kg, fortification recommended. Former preterms: enriched formula from discharge until 9–12 months corrected age. [1]
These are the lecturer's approximate energy targets, not a universal prescription. The maturity branch in the image should read preterm < 34 weeks and/or birth weight < 2 kg; the slide's “BW > 2 kg” is a typographical error. Current WHO guidance prioritizes mother's own milk, considers donor milk if unavailable, and conditionally considers multicomponent fortification for very preterm/VLBW infants; post-discharge enrichment is individualized rather than continued to a fixed age for every infant. [13]
| Condition | Formula Choice | Key Feature |
|---|---|---|
| Normal GI tract | Standard | Cow's milk protein, lactose, LCT |
| Lactose intolerance | Lactose-free | Contains milk/soy protein, no lactose |
| Malabsorption/intractable diarrhea/steatorrhea | Hydrolysed + MCT | MCT 30–55% of fat |
| Fat malabsorption/chylothorax/lymphatic disorders/short gut | MCT-enriched | MCT 84–90% of fat; LCT reduced |
| LC fatty acid oxidation defects (e.g. VLCAD) | MCT-enriched | Same as above |
Why MCT can help: Medium-chain fatty acids are more water-soluble and are absorbed more readily than long-chain fats, with much entering portal blood rather than chylomicrons/lymph. This can reduce dependence on bile-mediated micellar solubilization and lymphatic transport. It does not mean that all MCT behaves identically or that essential long-chain fatty acids can be omitted. Uses include:
- Cholestasis (bile salt deficiency)
- Chylothorax (lymphatic leak — LCT would worsen the chylous effusion)
- Short gut (reduced absorptive surface)
CRF/persistent hypercalcaemia: Renal formula (e.g. Similac PM 60/40) — low Ca, PO₄, K, iron. Cholestasis: MCT-enriched formula; most need fat-soluble vitamin supplementation (A, D, E, K). [1]
Why the pictured renal formula modifies minerals: Kidney disease can impair potassium/phosphate handling and alter calcium balance. The exact electrolyte, calcium, phosphate, protein, iron, and fluid prescription depends on the infant's disease and laboratories; “renal formula = low in everything” is unsafe shorthand.
Why fat-soluble vitamin supplementation in cholestasis: Bile salts are needed for fat-soluble vitamin absorption. In cholestasis, bile flow is impaired → malabsorption of vitamins A, D, E, K.
CMPA may be IgE- or non-IgE-mediated. Continue breastfeeding where possible; a time-limited maternal cow's-milk elimination trial is considered only when the breastfed infant has compatible symptoms, with nutritional support and planned reintroduction/challenge where safe to confirm the diagnosis. [1][17]
Suitable formulas:
| Formula | Features |
|---|---|
| Extensively hydrolysed formula (eHF) | Protein extensively broken down; first option for most non-breastfed infants with IgE- or non-IgE-mediated CMPA. Some products contain lactose, so “eHF = lactose-free” is not a class definition. |
| Amino-acid formula (AAF) | Free amino acids with no intact cow's-milk protein; reserve for severe/high-risk disease, eHF reaction/failure, or a specialist indication rather than calling it the routine “best” option. |
Unsuitable formulas for CMPA:
| Formula | Why NOT |
|---|---|
| Soy-based | Not first-line, especially under 6 months or in non-IgE gut disease; may be a later option in selected infants after considering soy sensitization, nutritional adequacy, acceptability, and local guidance. The slide's “consider in < 6 m” wording is misleading. |
| Partially hydrolysed | Contains peptides large enough to trigger reactions: not hypoallergenic and not treatment for established CMPA. Current allergy guidance does not support using hydrolysed formula as a reliable food-allergy-prevention strategy. [21] |
| Goat/sheep milk formula | Intact mammalian milk proteins commonly cross-react with cow's-milk proteins; not a treatment for CMPA. |
Goat Milk Cross-Reactivity — Common Exam Trap
The slide quotes 90% cross-reactivity as its exam figure. The clinically durable point is that goat milk is not a suitable substitute for confirmed CMPA because of substantial protein homology/cross-reactivity; do not rely on an exact percentage across every phenotype.
6.8 Indication 5: Inborn Errors of Metabolism (IEM)
General principle: In IEM, an enzyme defect causes:
- Accumulation of upstream substrate (toxic) → must restrict this in diet and enhance excretion
- Deficiency of downstream product → must supplement this
- Cofactor may enhance residual enzyme activity → supplement if applicable
“X-free formula” usually means a medical base mixture without that substrate. It is combined with a precisely measured amount of natural protein or the missing essential amino acid as required for growth; complete unsupervised elimination can itself be dangerous.
| Disorder | Special Formula |
|---|---|
| PKU | Phenylalanine-free |
| MSUD | BCAA-free (isoleucine, leucine, valine-free) |
| Homocystinuria | Methionine-free, cysteine-enriched |
| Tyrosinaemia | Phenylalanine- and tyrosine-free |
| Isovaleric acidaemia | Leucine-free |
For example, MSUD formula omits the branched-chain amino acids, but valine and isoleucine—and sometimes leucine—are titrated back under specialist biochemical monitoring because they are essential for growth.
The slide simplifies treatment to protein restriction plus essential amino acids; it maps proximal defects (NAGS, CPS1, OTC) to citrulline and distal defects (ASS1, ASL) to arginine. [1]
Why citrulline in proximal defects: The block occurs before citrulline synthesis, so citrulline can provide a downstream intermediate and support nitrogen disposal through the intact distal pathway.
Why arginine in distal defects: Arginine becomes conditionally essential and can promote excretion of nitrogen-containing intermediates. Exact therapy differs by defect and acute/chronic state and also uses adequate calories, nitrogen-scavenging drugs, emergency sick-day plans, and sometimes dialysis or transplantation—never formula selection alone.
| Disorder | Formula | Key Point |
|---|---|---|
| Galactosaemia | Lactose-free or soy-based | Breast milk CONTRAINDICATED (3.7g galactose/100ml); standard formula also contraindicated (3.5–4.3g/100ml) |
| VLCAD (fatty acid oxidation defect) | MCT-enriched | Very high MCT (84–90%), intact protein |
| Glutaric acidaemia type 1 | Lysine-free, tryptophan-reduced | |
| Propionic/methylmalonic acidaemia | Met, Val, Ile-free, Thr-reduced |
Galactosaemia — Breast Milk is CONTRAINDICATED
This is one of the few absolute contraindications to breastfeeding from the baby's side. Lactose in breast milk is broken down to glucose + galactose. In galactosaemia, galactose cannot be metabolized and accumulates, causing cataracts, liver failure, and intellectual disability. [1]
Boil water → clean surface/wash hands → sterilized bottle → fill with HOT WATER ≥ 70°C → add correct amount of powder → gently shake → cool → test temperature (lukewarm). [1]
Why ≥70°C? Powdered infant formula is not sterile and can contain Cronobacter. The slide/WHO-style method adds powder to water that remains at least 70°C, then cools the sealed bottle. Follow the product and local public-health instructions because preparation advice can differ for liquid concentrate, ready-to-feed formula, and certain specialist products. For high-risk infants, sterile ready-to-feed liquid formula may be preferred when available. [19]
The safety details omitted from the slide:
- Measure the water first, then add the exact number of level scoops; extra powder can cause dehydration and extra water causes undernutrition/hyponatraemia.
- Prepare one feed at a time where possible and never microwave it.
- Use a started feed within 1 hour and discard leftovers; if a prepared feed will not be started immediately, refrigerate promptly and follow the local/product storage limit (CDC: within 24 hours). [19]
7. Complementary Feeding (Weaning)
Complementary feeds "fill the gap" — BM alone insufficient to meet energy/nutritional needs. Gap widens as child grows. Slow/stop growing if gap not filled. Food types influenced by culture. By 2 years, breast milk entirely replaced by family foods. [1]
The energy-gap graphic shows a growing infant's total requirement rising above what milk alone can provide from about 6 months; complementary food fills the widening gap while breast milk or formula continues. The slide's statement that breast milk is “entirely replaced” by age 2 conflicts with current guidance: family foods progressively become the major nutritional source, but breastfeeding may continue to 2 years or beyond if mutually desired. [11][12][20]
At about 6 months, most term infants have the developmental and physiological maturity to start complementary foods. [1][20]
| Timing | Risk |
|---|---|
| Too early (< 4 months) | Usually lacks developmental readiness and may increase aspiration/choking risk; displaces milk without proven benefit |
| Unnecessarily delayed well beyond ~6 months | Increasing energy/iron gap; possible growth faltering, delayed texture/oromotor learning, and feeding aversion |
High Yield — Timing of Complementary Feeding
Start at about 6 months, when the infant can sit with support and maintain head control, coordinate reaching/grasping and swallowing, and shows interest in food. “Not after 6 months” is too rigid: readiness is not a birthday switch, but prolonged delay needs assessment. For preterm infants, combine corrected age, oral-motor readiness, growth, and neonatal/dietetic advice rather than applying the term-infant date mechanically. The slide's islet-cell-antibody association is not a useful stand-alone timing rule. [20]
Start with 1 food item. Gradual increase in consistency and variety. 6m: pureed/mashed/semi-solid. 8m: finger foods, self-feeding. 12m: family food, mature self-feeding. [1]
Feeding frequency: 2–3 times/day (6–8 months), 3–4 times/day (9–24 months), +1–2 nutritious snacks/day (12–24 months). [1]
Alternative approaches: "baby-led weaning" — infants share family food and self-feed with hand-held foods. [1]
The slide's maturation/timing table can be read as a skills progression:
| Developmental stage | Feeding implication |
|---|---|
| Birth | Suck–swallow reflex supports liquid feeding |
| ~4–6 months | Head/oral control and gastrointestinal/renal maturation permit smooth mashed foods when readiness is present |
| ~6–9 months | Progress from mashed foods to soft finger foods and a cup; sitting and hand-to-mouth skills improve |
| ~9–12 months | Lumpy/chopped textures and increasing self-feeding; move toward modified family foods |
| ~12 months onward | Family-textured foods with safe size/consistency; milk feeding continues as appropriate |
Do not keep an infant on smooth purées longer than necessary. Offer increasing texture and variety, energy-dense food, and iron-rich foods from the start. The reference-intake panel particularly highlights iron (11 mg/day at 7–12 months), zinc (3 mg/day), vitamin D (10 μg/400 IU/day), protein, essential fats, and total dietary diversity; these are reference values, not instructions to calculate every meal at home. Vegan feeding requires medical/dietetic supervision, especially for vitamin B12, vitamin D, iron, zinc, iodine, calcium, protein, and omega-3 fatty acids. [1][20]
Responsive feeding: seat the child safely, recognize hunger/satiety cues, encourage without force, minimize distraction, and assist self-feeding. The meal-frequency numbers are guides; appetite, breast/formula intake, energy density, growth, and illness modify the plan.
| DO's | DON'Ts |
|---|---|
| Introduce one new item every few days | No added salt or sugar |
| Mix cereal with BM/formula/water, thin texture first | Avoid: whole cow's milk; hard/round choking-risk foods (hot dogs, peanuts, grapes, raw carrots, popcorn, hard candies) |
| Feed with spoon, not bottle | Avoid honey (botulism risk) |
| Avoid low-nutritional drinks (tea, coffee, sugary beverages); limit juice |
Allergens: do not delay common allergens simply because they are allergens. Once complementary feeding begins, introduce cooked egg and smooth peanut in age-appropriate, non-choking forms, one at a time, and keep tolerated foods in the diet. Infants with severe eczema, existing food allergy, or a previous immediate reaction need individualized advice. Whole nuts remain a choking hazard. [21]
Why avoid honey before 12 months: Clostridium botulinum spores can be present in honey. The infant's immature gut flora cannot outcompete these spores, leading to infant botulism — a potentially fatal flaccid paralysis.
Why avoid cow's milk as the main drink before 12 months: It is iron-poor and is not formulated to provide the complete nutrient profile of breast milk or infant formula. Pasteurized cow's milk can still be used in small amounts in cooking/foods from around 6 months, and dairy foods are not prohibited unless allergy is present.
The final slide lists growth/body composition, neurodevelopment, microbiota, infection/immune outcomes, allergy, coeliac disease, type 1 diabetes, and cardiovascular health as domains studied in relation to complementary feeding. [1]
These are outcome domains, not a claim that one weaning method prevents each disease. Timing, food quality and diversity, iron adequacy, texture progression, responsive feeding, and choking/food-safety precautions are the actionable takeaways.
The 2025 Fourth Summative MCQ Q9 asked: "A 27-year-old woman complained of fullness and tenderness in her left breast after exclusive breastfeeding for 1 week. What method can be considered to alleviate the symptoms?" Answer: D. Try to express the milk by breast pump. [6]
Best answer among the options: D. This tests recognition of engorgement rather than infection or an indication to suppress lactation. The modern practical interpretation is physiological feeding plus small-volume expression for comfort or to soften a tense areola, not repeated pumping to empty the breast. [22]
The other options are wrong because:
- Switching to formula (would worsen engorgement by not emptying the breast)
- Cabergoline (dopamine agonist that suppresses prolactin — only used to suppress lactation entirely, e.g. stillbirth)
- Antibiotics (engorgement is not bacterial mastitis)
Distinction: Engorgement → Mastitis → Abscess
| Stage | Features | Management |
|---|---|---|
| Engorgement | Usually days 3–5; bilateral diffuse firmness/swelling | Cue-based feeding, correct latch/transfer, reverse-pressure softening; express a small amount if needed; ice and compatible analgesia |
| Ductal narrowing / inflammatory mastitis | Local tenderness/induration ± erythema; systemic inflammatory symptoms can occur without bacterial infection | Physiological feeding, ice/NSAID if suitable, rest; avoid deep massage, repeated heat, and pumping to empty |
| Bacterial mastitis | Progressive focal inflammation/systemic illness or non-resolution suggesting bacterial overgrowth | Continue physiological feeding, appropriate anti-staphylococcal antibiotic per local guidance; culture if severe/recurrent or not improving |
| Abscess | Persistent focal collection, often confirmed by ultrasound | Drainage/source control + culture-directed antibiotics; continue milk feeding where feasible |
A past-paper paraphrase describes inability to lactate and amenorrhoea after severe postpartum haemorrhage. [7]
Sheehan syndrome = pituitary infarction due to severe postpartum haemorrhage. The pituitary gland is enlarged during pregnancy (lactotroph hyperplasia) and is vulnerable to ischaemia. Loss of anterior pituitary function causes:
- Failure of lactation (↓ prolactin)
- Amenorrhoea (↓ FSH/LH)
- Hypothyroidism (↓ TSH)
- Adrenal insufficiency (↓ ACTH)
Safety correction: Sheehan syndrome classically causes anterior hypopituitarism. Arginine-vasopressin deficiency/central diabetes insipidus requires posterior pituitary or stalk involvement and is uncommon, not the expected associated deficit. If an MCQ offers central DI, check whether the stem asks for the least likely feature; do not memorize it as a routine manifestation of Sheehan syndrome.
High Yield Summary
- Growth and maturation: assess weight, length and head circumference longitudinally. Coordinated suck–swallow–breathe usually develops at ~33–36 weeks; younger preterms commonly need tube feeding.
- Human milk is dynamic: preterm milk is initially richer in protein/energy than term milk, and milk contains antimicrobial, anti-inflammatory and immunomodulating factors. Long-term disease claims vary in evidence strength.
- Preterm hierarchy: mother's own milk → donor human milk when needed/available → individualized fortification for very preterm/VLBW infants; nutrient-enriched preterm formula when human milk options are unavailable or insufficient.
- Early feeding problems: assess attachment and transfer. The “foremilk–hindmilk imbalance” label is overused; the fat curve is gradual and green stool alone is not diagnostic.
- Jaundice/weight-loss cycle: low intake increases enterohepatic bilirubin reabsorption and lethargy further impairs feeding. Excessive loss or poor output triggers a full assessment; never dismiss possible hypernatraemia.
- Hypoglycaemia: preterm, SGA, sick/hypothermic/asphyxiated infants and infants of diabetic or beta-blocked mothers need risk-based screening and early feeding. The ketone graphs illustrate adaptation, not safe glucose thresholds.
- Formula selection is diagnosis-based: standard/preterm, lactose-free, eHF/AAF, MCT, renal and metabolic formulas are not interchangeable. eHF is first-line for most CMPA; AAF is reserved for severe disease or eHF failure; partially hydrolysed and goat milk formulas do not treat CMPA.
- IEM diagram: restrict the toxic precursor to a prescribed safe amount, prevent catabolism, supply other nutrients/downstream products, and enhance detoxification under specialist monitoring. “Amino-acid-free” mixtures are not complete feeds used alone.
- Complementary feeding: begin at about 6 months when developmentally ready; prioritize iron-rich, diverse foods, responsive feeding and texture progression. Avoid honey < 12 months, cow's milk as the main drink < 12 months, sugary drinks and choking hazards; do not unnecessarily delay allergens.
- Formula safety: powder is not sterile. Measure water first, use the exact powder ratio, follow the ≥70°C/local preparation method, cool safely, and discard a started feed after 1 hour.
Active Recall - Lecture Notes
[1] Lecture slides: CFB (OGPAE02-2) Physiology of Lactation, Breast Feeding and Infant Feeding (Part II).pdf [2] Senior notes: Adrian Lui Pediatrics Notes.pdf (Section 3.3 Nutrition and Fluid) [3] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (Section on pathophysiology of nutrition uptake in infants) [4] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (Section on breastmilk jaundice vs breastfeeding jaundice) [5] Paediatrics lecture slides: Block C - A jaundiced child.pdf (Slide on enterohepatic circulation) [6] Past papers: 2025 Fourth Summative MCQ.pdf (Question 9) [7] Past papers: 2023 Fourth Summative MCQ.pdf (Question 38) [8] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (Section on lactational mastitis) [9] Senior notes: Ryan Ho Urogenital.pdf (Section 9.3 Inflammatory Breast Conditions) [10] Academy of Breastfeeding Medicine. Clinical Protocol #2: Guidelines for Birth Hospitalization Discharge of Breastfeeding Dyads, Revised 2022. [11] Meek JY, Noble L; American Academy of Pediatrics. Breastfeeding and the Use of Human Milk: Policy Statement. Pediatrics. 2022;150:e2022057988. [12] World Health Organization. Infant and young child feeding (including HIV and continued-breastfeeding guidance; accessed 2026). [13] World Health Organization. WHO recommendations for care of the preterm or low-birth-weight infant. 2022. [14] World Health Organization and UNICEF. Implementation guidance: the revised Baby-friendly Hospital Initiative. 2018. [15] Hong Kong Centre for Food Safety. Regulation for Formula Products and Foods for Infants and Young Children (Food and Drugs (Composition and Labelling) (Amendment) (No. 2) Regulation 2014). [16] US Centers for Disease Control and Prevention. Jaundice and Breastfeeding (updated 2025). [17] World Allergy Organization DRACMA guideline update XII. Recommendations on milk formula supplements for infants and toddlers with cow's-milk allergy. World Allergy Organization Journal. 2024. [18] US Food and Drug Administration. Infant Formula Information for Parents & Caregivers (routine versus specialty formulas; accessed 2026). [19] US Centers for Disease Control and Prevention. Infant Formula Preparation and Storage (accessed 2026). [20] World Health Organization. Guideline for complementary feeding of infants and young children 6–23 months of age. 2023. [21] Australasian Society of Clinical Immunology and Allergy. Infant Feeding for Food Allergy Prevention (2026 recommendations). [22] Mitchell KB, et al. Academy of Breastfeeding Medicine Clinical Protocol #36: The Mastitis Spectrum, Revised 2022. Breastfeeding Medicine. 2022;17(5):360–376.
CFB OGPAE02-1 Physiology Of Lactation, Breast Feeding And Infant Feeding (part I)
Lactation physiology encompasses the hormonal mechanisms of mammogenesis, lactogenesis, and galactopoiesis, along with the principles of breastfeeding initiation and infant nutritional requirements in the early postnatal period.
CFB OG01 Physiology Of Pregnancy And Minor Ailments
Physiology of pregnancy encompasses the maternal anatomical and physiological adaptations—cardiovascular, respiratory, renal, endocrine, and hematological—that support fetal development, along with the common minor ailments such as nausea, heartburn, constipation, varicose veins, and backache that arise from these changes.